Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIH to Create GenPort Genomics Portal

by Global Biodefense Staff
April 10, 2015
Genomic Sequencing Standards USAMRIID

Image credit: Shutterstock

The National Institutes of Health (NIH) is seeking a small business with the ability to create and operate a genomics portal (GenPort) that will provide researchers access to genomic and phenotypic data from multiple cohort studies, together with tools for creating synthetic cohorts and performing statistical analyses.

Omics data from well phenotyped human cohorts are an invaluable window into the involvement of particular molecules and pathways in diseases. While much omics data has been made accessible through programs such as dbGaP, most investigators lack the bioinformatic expertise and computational tools that are required to analyze available data.

Hence, there is widespread interest in developing tools that will provide non-informatic scientists, as well as informaticians, the opportunity to probe multi-platform, individual-level omics data. Providing wider access to omics data will help to focus basic science and human biomarker research on pathways and systems that are most relevant to human disease.

The GenPort program is expected to leverage and be interoperable with NIH’s NIH Big Data to Knowledge (BD2K) initiative, which is currently developing tools for integration and analysis of large, multi-dimensional data sets.

The selected GenPort contractor is expected to use general methods and approaches being developed through other efforts such as BD2K, to customize those tools to the data characteristics, scientific questions, and investigator capabilities.

Further details are available via Solicitation Number: HHS-NIH-NHLBI-RDSS-HR-16-15. The response deadline is April 27, 2015.

Tags: BiomarkersNIHRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC